The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Serotonin and Blood Pressure Regulation
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
The sympathetic control of blood pressure
Guyenet, P. G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1902 · Cited by 1,863
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J.-U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bader, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,570
TWO KINDS OF TRYPTAMINE RECEPTOR
GADDUM, J. H., & PICARELLI, Z. P. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00142.x · Cited by 847
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
A unique central tryptophan hydroxylase isoform
Walther, D. J., & Bader, M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00556-2 · Cited by 751
ERSPAMER, V., & ASERO, B. (1952) · Nature · doi:10.1038/169800b0 · Cited by 670
SERUM VASOCONSTRICTOR (SEROTONIN)
Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57137-4 · Cited by 552
Azmitia, E. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00614-1 · Cited by 497
Côté, F., Thévenot, E., Fligny, C., Fromes, Y., Darmon, M., Ripoche, M.-A., Bayard, E., Hanoun, N., Saurini, F., Lechat, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233056100 · Cited by 483
Drugs and Valvular Heart Disease
Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479 · cited 1×
“Significant interest has been paid to the expression of 5-HT receptors on aortic valves (especially the 5-HT 2B receptor), because the 5-HT releaser and weight-loss drug fenfluramine causes valvular dysfunction (Roth, 2007; Huang et al., 2009; Hajjo et al., 2010).”
BackgroundCardiovascular effects of anemia
Varat, M. A., Adolph, R. J., & Fowler, N. O. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90445-0 · Cited by 429
Paulmann, N., Grohmann, M., Voigt, J.-P., Bert, B., Vowinckel, J., Bader, M., Skelin, M., Jevšek, M., Fink, H., Rupnik, M., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000229 · Cited by 404
Chen, J. J., Li, Z., Pan, H., Murphy, D. L., Tamir, H., Koepsell, H., & Gershon, M. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06348.2001 · Cited by 397
Growth retardation and altered autonomic control in mice lacking brain serotonin
Alenina, N., Kikic, D., Todiras, M., Mosienko, V., Qadri, F., Plehm, R., Boyé, P., Vilianovitch, L., Sohr, R., Tenner, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810793106 · Cited by 347
Thase, M. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1002 · Cited by 331 · cited 1×
“A number of meta-analyses have been performed in this regard (Thase, 1998; Kim et al., 2003; de Lemos et al., 2008; Johansson et al., 2010).”
BackgroundSerotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan
Turner, E. H., Loftis, J. M., & Blackwell, A. D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.004 · Cited by 326
Serotonin Syndrome Presentation of 2 Cases and Review of the Literature
Mason, P. J., Morris, V. A., & Balcezak, T. J. (2000) · Medicine · doi:10.1097/00005792-200007000-00001 · Cited by 309
5-Hydroxytryptamine receptors in the human cardiovascular system
Kaumann, A. J., & Levy, F. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.004 · Cited by 309
CONGENITAL HEMIHYPERTROPHY AND MALIGNANCY
Benson, P. F., Vulliamy, D. G., & Taubman, J. O. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92360-2 · Cited by 291
Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood‐brain interface
Hardebo, J. E., & Owman, C. (1980) · Annals of Neurology · doi:10.1002/ana.410080102 · Cited by 267
Savelieva, K. V., Zhao, S., Pogorelov, V. M., Rajan, I., Yang, Q., Cullinan, E., & Lanthorn, T. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003301 · Cited by 265
Homberg, J. R., Olivier, J. D. A., Smits, B. M. G., Mul, J. D., Mudde, J., Verheul, M., Nieuwenhuizen, O. F. M., Cools, A. R., Ronken, E., Cremers, T., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.030 · Cited by 259
McMahon, F. G., Fujioka, K., Singh, B. N., Mendel, C. M., Rowe, E., Rolston, K., Johnson, F., & Mooradian, A. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2185 · Cited by 247
Review of the role of the central serotonergic neuronal system in blood pressure regulation.
Kuhn, D. M., Wolf, W. A., & Lovenberg, W. (1980) · Hypertension · doi:10.1161/01.hyp.2.3.243 · Cited by 246
SERUM VASOCONSTRICTOR (SEROTONIN)
Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57136-2 · Cited by 225
Daws, L. C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.004 · Cited by 223
5-Hydroxytryptamine and cardiovascular regulation
RAMAGE, A., & VILLALON, C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.009 · Cited by 218
Fozard, J. R., Mir, A. K., & Middlemiss, D. N. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198703000-00010 · Cited by 212
5-Hydroxytryptophan: a clinically-effective serotonin precursor.
Birdsall, T. C. (1998) · PubMed · Cited by 202
Villalón, C. M., & Centurión, D. (2007) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-007-0179-1 · Cited by 192
Monoamine Oxidase Inhibitors:A Modern Guide to an Unrequited Class of Antidepressants
Stahl, S. M., & Felker, A. (2008) · CNS Spectrums · doi:10.1017/s1092852900016965 · Cited by 191
Plasma serotonin levels and the platelet serotonin transporter
Brenner, B., Harney, J. T., Ahmed, B. A., Jeffus, B. C., Unal, R., Mehta, J. L., & Kilic, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04542.x · Cited by 188
Central Pathways Controlling Brown Adipose Tissue Thermogenesis
Morrison, S. F. (2004) · Physiology · doi:10.1152/nips.01502.2003 · Cited by 186
Self-citationBAGDY, G., MURPHY, D. L., & SZEMEREDI, K. (1989) · Endocrinology · doi:10.1210/endo-125-5-2664 · Cited by 181
Chanrion, B., Mannoury la Cour, C., Bertaso, F., Lerner-Natoli, M., Freissmuth, M., Millan, M. J., Bockaert, J., & Marin, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610964104 · Cited by 180
Serotonin‐ and substance P‐containing projections to the nucleus tractus solitarii of the rat
Thor, K. B., & Helke, C. J. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902650210 · Cited by 172
Roux, F., & Couraud, P.-O. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1376-9 · Cited by 172
Pierce, P. A., Xie, G.-X., Levine, J. D., & Peroutka, S. J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00329-0 · Cited by 162
Central cardiovascular regulation and 5-hydroxytryptamine receptors
Ramage, A. G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00612-8 · Cited by 158
Nebigil, C. G., Étienne-Selloum, N., Messaddeq, N., & Maroteaux, L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1122fje · Cited by 158
CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSION
Glassman, A. H., Bigger, J. T., GGiardina, E., Kantor, S. J., Perel, J., & Davies, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90824-9 · Cited by 156
Vascular receptors for 5-hydroxytryptamine: Distribution, function and classification
Martin, G. R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90048-5 · Cited by 155
Krobert, K. A., Bach, T., Syversveen, T., Kvingedal, A. M., & Levy, F. O. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000369 · Cited by 152
Huang, X., Setola, V., Yadav, P. N., Allen, J., Rogan, S. C., Hanson, B. J., Revankar, C. M., Robers, M., Doucette, C., & Roth, B. L. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058057 · Cited by 150
Recent advances in understanding serotonin regulation of cardiovascular function
Côté, F., Fligny, C., Fromes, Y., Mallet, J. J., & Vodjdani, G. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.03.007 · Cited by 146
Vagal control of the heart: central serotonergic (5‐HT) mechanisms
Jordan, D. (2004) · Experimental Physiology · doi:10.1113/expphysiol.2004.029058 · Cited by 145
Nebigil, C. G., Jaffré, F., Messaddeq, N., Hickel, P., Monassier, L., Launay, J., & Maroteaux, L. (2003) · Circulation · doi:10.1161/01.cir.0000074224.57016.01 · Cited by 144
Sprouse, J. S., Reynolds, L. S., Li, X., Braselton, J. P., & Schmidt, A. W. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.007 · Cited by 144
PDZ-dependent Activation of Nitric-oxide Synthases by the Serotonin 2B Receptor
Manivet, P., Mouillet‐Richard, S., Callebert, J., Nebigil, C. G., Maroteaux, L., Hosoda, S., Kellermann, O., & Launay, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9324 · Cited by 141
Treatment of acute migraine headache.
Gilmore, B., & Michael, M. (2011) · PubMed · Cited by 139
Activation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache?
Schmuck, K., Ullmer, C., Kalkman, H. O., Probst, A., & Lübbert, H. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01583.x · Cited by 131
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes
Afergan, E., Epstein-Barash, H., Dahan, R., Koroukhov, N., Rohekar, K., Danenberg, H. D., & Golomb, G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.017 · Cited by 130
Morecroft, I., Dempsie, Y., Bäder, M., Walther, D. J., Kotnik, K., Loughlin, L., Nilsen, M., & MacLean, M. R. (2006) · Hypertension · doi:10.1161/01.hyp.0000252210.58849.78 · Cited by 128
Nilsson, T., Longmore, J., Shaw, D. E., Olesen, I. J., & Edvinsson, L. I. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702773 · Cited by 125
Brand, T., & Anderson, G. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.163824 · Cited by 124
Augmented brain 5‐HT crosses the blood–brain barrier through the 5‐HT transporter in rat
Nakatani, Y., Sato‐Suzuki, I., Tsujino, N., Nakasato, A., Seki, Y., Fumoto, M., & Arita, H. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06201.x · Cited by 121
Salter, M., Hazelwood, R., Pogson, C. I., Iyer, R., & Madge, D. J. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00006-l · Cited by 119
Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
McCall, R. B., & Clement, M. E. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06806-1 · Cited by 117
Cohen, M. L., Fuller, R. W., & Kurz, K. D. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22026-2 · Cited by 116
Pathophysiology, Diagnosis, and Treatment of Orthostatic Hypotension and Vasovagal Syncope
Medow, M. S., Stewart, J. M., Sanyal, S., Mumtaz, A., Sica, D. A., & Frishman, W. H. (2007) · Cardiology in Review · doi:10.1097/crd.0b013e31815c8032 · Cited by 114
Ye, P., Mariniello, B., Mantero, F., Shibata, H., & Rainey, W. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0037 · Cited by 113
Skop, B. P., Finkelstein, J. A., Mareth, T. R., Magoon, M. R., & Brown, T. M. (1994) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(94)90031-0 · Cited by 109
Enhanced vesicular transport of exogenous peroxidase across cerebral vessels, induced by serotonin
Westergaard, E. (1975) · Acta Neuropathologica · doi:10.1007/bf00686065 · Cited by 109
Effect of Sibutramine on Weight Loss and Blood Pressure: A Meta‐analysis of Controlled Trials
Kim, S. H., Lee, Y., Jee, S. H., & Nam, C. M. (2003) · Obesity Research · doi:10.1038/oby.2003.152 · Cited by 106
Serotonin and its transporter on proliferation of fetal heart cells
Sari, Y., & Zhou, F. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2003.10.002 · Cited by 105
Neuropharmacology of 5‐hydroxytryptamine
Green, A. R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706427 · Cited by 104
A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor‐independent ROS generation
Bianchi, P., Pimentel, D. R., Murphy, M. P., Colucci, W. S., & Parini, A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2518fje · Cited by 104
Verhofstad, A. A. J., & JONSSON, G. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90125-2 · Cited by 101
Kema, I. P., Meijer, W. G., Meiborg, G., Ooms, B., Willemse, P. H. B., & de Vries, E. G. E. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1811 · Cited by 101
Mediation by 5‐hydroxytryptamine2Breceptors of endothelium‐dependent relaxation in rat jugular vein
Ellis, E. S., Byrne, C., Murphy, O. E., Tilford, N. S., & Baxter, G. S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13240.x · Cited by 100
Ohtsuki, S. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1489 · Cited by 99
Bouchelet, I., Case, B. W., Olivier, A., & Hamel, É. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703081 · Cited by 97
5-HT in systemic hypertension: foe, friend or fantasy?
Watts, S. W. (2005) · Clinical Science · doi:10.1042/cs20040364 · Cited by 96
Self-citationChalon, S., Granier, L., Vandenhende, F., Bieck, P. R., Bymaster, F. P., Joliat, M. J., Hirth, C., & Potter, W. Z. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300209 · Cited by 95
Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection
Maurer‐Spurej, E. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4262-1 · Cited by 93
Serotonin potentiates sympathetic responses evoked by spinal NMDA
Madden, C. J., & Morrison, S. F. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.116574 · Cited by 93
Self-citationA Novel Role for Serotonin in Heart
Nebigil, C. G. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00135-9 · Cited by 90
Serotonin and pulmonary hypertension—from bench to bedside?
MacLean, M. R., & Dempsie, Y. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.02.005 · Cited by 90
Terrón, J. A., & Falcón‐Neri, A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702580 · Cited by 90
Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells
Wakayama, K., Ohtsuki, S., Takanaga, H., Hosoya, K., & Terasaki, T. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00120-7 · Cited by 88
Blessing, W. W., & Seaman, B. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00810-2 · Cited by 87
Safety of 5-hydroxy-l-tryptophan
Das, Y. T., Bagchi, M., Bagchi, D., & Preuss, H. G. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.070 · Cited by 85
Cardiovascular effects of imipramine and nortriptyline in elderly patients
Thayssen, P., Bjerre, M. T., Kragh-S�rensen, P., M�ller, M., Petersen, O. L., Kristensen, C. B., & Gram, L. F. (1981) · Psychopharmacology · doi:10.1007/bf00432748 · Cited by 81
Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)
Tytgat, J., Maertens, C., & Daenens, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701545 · Cited by 79
Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease
Turkka, J. T., Suominen, K., Tolonen, U., Sotaniemi, K. A., & Myllylä, V. V. (1997) · Neurology · doi:10.1212/wnl.48.3.662 · Cited by 79
Saletu, B., Gr�nberger, J., & Linzmayer, L. (1986) · Journal of Neural Transmission · doi:10.1007/bf01243351 · Cited by 78
Lenglet, S., Louiset, E., Delarue, C., Vaudry, H., & Contesse, V. (2002) · Endocrinology · doi:10.1210/endo.143.5.8817 · Cited by 78
The existence of a local 5‐hydroxytryptaminergic system in peripheral arteries
Ni, W., Geddes, T. J., Priestley, J. R. C., Szasz, T., Kuhn, D. M., & Watts, S. W. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.111 · Cited by 76
Self-citationAnderson, I. K., Martin, G. R., & Ramage, A. G. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13401.x · Cited by 74
Wood, M. D., Chaubey, M., Atkinson, P. J., & Thomas, D. R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00213-2 · Cited by 73
Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension
Grubb, B. P., Samoil, D., KOSINSKI, D. J., Wolfe, D. A., Lorton, M., & Madu, E. C. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90304-2 · Cited by 71
Nosjean, A., Compoint, C., Buisseret-Delmas, C., Orer, H. S., Merahi, N., Puizillout, J. J., & Laguzzi, R. F. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90422-6 · Cited by 70
Barman, S. M., & Gebber, G. L. (2000) · Journal of Biological Rhythms · doi:10.1177/074873000129001468 · Cited by 69
Self-citationSerotonin Coexists with Epinephrine in Rat Adrenal Medullary Cells
Holzwarth, M. A., & Brownfield, M. S. (2008) · Neuroendocrinology · doi:10.1159/000124182 · Cited by 69
Pickering, A. E., Spanswick, D. C., & Logan, S. D. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020345 · Cited by 67
A double‐blind controlled clinical trial comparing fluvoxamine with imipramine.
Guelfi, J., Dreyfus, J. F., & Pichot, P. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02131.x · Cited by 67
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon
Biondi, M. L., Marasini, B., Bianchi, E., et al. (1988) · International Journal of Cardiology · doi:10.1016/0167-5273(88)90238-0 · Cited by 67
Molderings, G. J., Werner, K., Likungu, J., & G�thert, M. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169451 · Cited by 66
Cohen, M. L., Fuller, R. W., & Kurz, K. D. (1983) · Hypertension · doi:10.1161/01.hyp.5.5.676 · Cited by 66
Nagatsu, I., Ichinose, H., Sakai, M., Titani, K., Suzuki, M., & Nagatsu, T. (1995) · Journal of Neural Transmission · doi:10.1007/bf01281153 · Cited by 65
Pedersen, O. L., Kragh-S�rensen, P., Bjerre, M. T., Over�, K. F., & Gram, L. F. (1982) · Psychopharmacology · doi:10.1007/bf00464566 · Cited by 64
Presynaptic Receptors for Dopamine, Histamine, and Serotonin
Feuerstein, T. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_10 · Cited by 63
Waeber, C., & Moskowitz, M. A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00275-p · Cited by 63
5-HT receptors in human and animal cerebrovasculature
Parsons, A. A. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90583-e · Cited by 63
Alkadhi, K. A., Alzoubi, K. H., Aleisa, A. M., Tanner, F. L., & Nimer, A. S. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.020 · Cited by 62
Lamping, K. G., & Faraci, F. M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.523 · Cited by 62
Doggrell, S. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.5.805 · Cited by 62
Laguzzi, R. F. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025096718559 · Cited by 60
5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats
Watts, S. W., & Fink, G. D. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.3.h944 · Cited by 58
Self-citationAbumaria, N., Ribic, A., Anacker, C., Fuchs, E., & Flügge, G. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9259-5 · Cited by 57
Monoamine oxidase inhibitors in resistant major depression
Nolen, W. A., Haffmans, P. M. J., Bouvy, P. F., & Duivenvoorden, H. J. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90104-r · Cited by 56
5-Hydroxytryptamine Lowers Blood Pressure in Normotensive and Hypertensive Rats
Diaz, J., Ni, W., Thompson, J., King, A., Fink, G. D., & Watts, S. W. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136226 · Cited by 56
Self-citationBrust, P., Friedrich, A., Krizbai, I. A., Bergmann, R., Roux, F. S., Ganapathy, V., & Johannsen, B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741241.x · Cited by 55
The Serotonin Transporter is Present and Functional in Peripheral Arterial Smooth Muscle
Ni, W., Thompson, J., Northcott, C. A., Lookingland, K. J., & Watts, S. W. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200406000-00006 · Cited by 55
Self-citationStudies on the antihypertensive action of L-tryptophan.
Sved, A. F., Itallie, C. M. V., & Fernstrom, J. D. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33062-4 · Cited by 55
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas
Cartier, D., Jégou, S., Parmentier, F., Lihrmann, I., Louiset, E., Kuhn, J., Bastard, C., Plouin, P., Godin, M., Vaudry, H., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02051 · Cited by 53
Halder, I., Muldoon, M. F., Ferrell, R. E., & Manuck, S. B. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0008 · Cited by 52
McKune, C. M., & Watts, S. W. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29514-8 · Cited by 52
Self-citationEffects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure
Ross, R. J. M., Zavadil, A. P., Calil, H. M., et al. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.58 · Cited by 51
Blood Pressure Changes During Short-Term Fluoxetine Treatment
Amsterdam, J. D., Garcia-Espana, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00004 · Cited by 51
Hajjo, R., Grulke, C., Golbraikh, A., Setola, V., Huang, X., Roth, B. L., & Tropsha, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100600y · Cited by 50
Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder
Mbaya, P., Alam, F. D., Ashim, S., & BENNETT, D. H. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.834 · Cited by 50
Central 5-HT receptors in cardiovascular control during stress
Nalivaiko, E., & Sgoifo, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.026 · Cited by 49
The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system
Penttilä, J., Syvälahti, E. K. G., Hinkka‐Yli‐Salomäki, S., Kuusela, T., & Scheinin, H. (2001) · Psychopharmacology · doi:10.1007/s002130000664 · Cited by 48
Valentin, J., Bonnafous, R., & John, G. W. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15674.x · Cited by 48
Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man
Murphy, D. L., Lipper, S., Slater, S., et al. (1979) · Psychopharmacology · doi:10.1007/bf00427125 · Cited by 48
Serotonin, hypertension and vascular disease.
Pm, V. (1991) · PubMed · Cited by 48
Lewis, D. I., & Coote, J. H. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb12987.x · Cited by 47
Ootsuka, Y., & Blessing, W. W. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00564.2004 · Cited by 47
Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Ueno, M. (2009) · Current Neuropharmacology · doi:10.2174/157015909788848901 · Cited by 46
Giardina, E. V., Johnson, L. L., Vita, J. A., Bigger, J. T., & Brem, R. F. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90240-6 · Cited by 44
Mankad, P. S., Chester, A. H., & Yacoub, M. H. (1991) · Cardiovascular Research · doi:10.1093/cvr/25.3.244 · Cited by 43
Nichols, C. D. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/475108 · Cited by 43
Ishida, T., Kawashima, S., Hirata, K., Sakoda, T., Shimokawa, Y., Miwa, Y., Inoue, N., Ueyama, T., Shiomi, M., Akita, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.9.1289 · Cited by 43
Serotonin distribution in the circumventricular organs of the rat
Takeuchi, Y., & Sano, Y. (1983) · Anatomy and Embryology · doi:10.1007/bf00315669 · Cited by 43
Long‐term changes in blood pressure following orlistat and sibutramine treatment: a meta‐analysis
Johansson, K., Sundström, J., Neovius, K., Rössner, S., & Neovius, M. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00693.x · Cited by 42
Wan, S., & Browning, K. N. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90288.2008 · Cited by 42
Knowles, I. D., & Ramage, A. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702822 · Cited by 41
Carrasco, G. A., Cruz, M. A., Gallaido, V., Miguel, P., Lagos, M., & González, C. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00066-6 · Cited by 40
Ootsuka, Y., & Blessing, W. W. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.031 · Cited by 40
Meyer, T., & Brinck, U. (1999) · Digestion · doi:10.1159/000007590 · Cited by 40
Contesse, V., Lenglet, S., Grumolato, L., et al. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.552 · Cited by 40
Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
Cohen, R. A. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24919-9 · Cited by 38
Helke, C. J., McDonald, C. H., & Phillips, E. T. (1993) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(93)90048-y · Cited by 38
Monassier, L., Laplante, M., Ayadi, T., Doly, S., & Maroteaux, L. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.004 · Cited by 37
Hamel, É., Robert, J. P., Young, A. R., & MacKenzie, E. T. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23512-1 · Cited by 36
The Effects of Supratherapeutic Doses of Duloxetine on Blood Pressure and Pulse Rate
Derby, M. A., Zhang, L., Chappell, J. C., Gonzales, C., Callaghan, J. T., Leibowitz, M. T., Ereshefsky, L., Hoelscher, D. D., Leese, P. T., & Mitchell, M. I. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31804d1cce · Cited by 36
Moreira, T. S., Takakura, A. C. T., Colombari, E., & Guyenet, P. G. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00675.2007 · Cited by 35
Orthostatic side effects of clomipramine and citalopram during treatment for depression
Christensen, P., Thomsen, H. Y., Pedersen, O. L., Gram, L. F., & Kragh-S�rensen, P. (1985) · Psychopharmacology · doi:10.1007/bf00427895 · Cited by 35
Comet, M. ‐., Bernard, J., Hamon, M., Laguzzi, R. F., & Sévoz‐Couche, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05673.x · Cited by 34
Brownfield, M. S., Poff, B. C., & Holzwarth, M. A. (1985) · Histochemistry and Cell Biology · doi:10.1007/bf00495298 · Cited by 34
Monaghan, P. J., Brown, H. A., Houghton, L. A., & Keevil, B. G. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.05.045 · Cited by 33
Nigmatullina, R. R., Кириллова, В. В., Jourjikiya, R. K., Mukhamedyarov, M. A., Кудрин, В. С., Михайлович, К. П., & Palotás, A. (2009) · Cardiology · doi:10.1159/000205962 · Cited by 33
Serotonergic Receptors and Drugs in Hypertension
van Zwieten, P. A., Blauw, G. J., & van Brummelen, P. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb01617.x · Cited by 33
Regional vascular effects of serotonin and ketanserin in young, healthy subjects.
Blauw, G. J., van Brummelen, P., Chang, P. C., Vermeij, P., & van Zwieten, P. A. (1988) · Hypertension · doi:10.1161/01.hyp.11.3.256 · Cited by 33
Rajapakse, S., Abeynaike, L., & Wickramarathne, T. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ee2ae7 · Cited by 32
SEROTONIN (5HT) AND ITS ANTAGONISTS: INVOLVEMENT IN THE CARDIOV ASCULAR SYSTEM
Marwood, J. F., & Stokes, G. S. (1984) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1984.tb00852.x · Cited by 32
Absence of Cardiovascular Adverse Effects of Sertraline in Children and Adolescents
Wilens, T. E., Biederman, J., March, J. S., Wolkow, R., FINE, C. S., Millstein, R., Faraone, S. V., GELLER, D. A., & Spencer, T. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00019 · Cited by 32
Communication between 5-HT and small GTPases
Mercado, C. P., Ziu, E., & Kilic, F. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.01.006 · Cited by 31
Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat
Linder, A. E., Diaz, J., Ni, W., Szasz, T., Burnett, R. J., & Watts, S. W. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91415.2007 · Cited by 31
Self-citationDuloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy.
Bailey, R. K., Mallinckrodt, C. H., Wohlreich, M. M., Watkin, J. G., & Plewes, J. M. (2006) · PubMed Central · Cited by 30
Sharma, A. M., Caterson, I. D., Coutinho, W. F., Finer, N., Gaal, L. V., Maggioni, A. P., Torp-Pedersen, C. T., Bacher, H. P., Shepherd, G., James, W. P. T., et al. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00930.x · Cited by 30
Jones, J. F. X., Martin, G. R., & Ramage, A. G. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16651.x · Cited by 30
A Serotonergic System in Veins: Serotonin Transporter-Independent Uptake
Linder, A. E., Ni, W., Szasz, T., Burnett, R. J., Diaz, J., Geddes, T. J., Kuhn, D. M., & Watts, S. W. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135699 · Cited by 29
Self-citationBody distribution of infused serotonin in rats
Linder, A. E., Beggs, K. M., Burnett, R. J., & Watts, S. W. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05147.x · Cited by 28
Self-citationSerotonin synthesis in adrenochromaffin cells
Delarue, C., Becquet, D., Idres, S., Hery, F., & Vaudry, H. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90069-e · Cited by 28
Verheggen, R., Freudenthaler, S. M., Meyer‐Dulheuer, F., & Kaumann, A. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15188.x · Cited by 28
5-Hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes
Ikeda, K., Tojo, K., Otsubo, C., Udagawa, T., Kumazawa, K., Ishikawa, M., Tokudome, G., Hosoya, T., Tajima, N., Claycomb, W. C., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.018 · Cited by 28
A note on the discovery of selective serotonin reuptake inhibitors
Carlsson, A., & Wong, D. T. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00662-0 · Cited by 28
Ogura, C., Kishimoto, A., Mizukawa, R., Hazama, H., Honma, H., & Kawahara, K. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542525 · Cited by 27
Birkenfeld, A. L., Schroeder, C., Pischon, T., Tank, J., Luft, F. C., Sharma, A. M., & Jordan, J. (2005) · Clinical Autonomic Research · doi:10.1007/s10286-005-0270-y · Cited by 27
Hafdi‐Nejjari, Z., Couette, S., Comoy, E., Prié, D., Amiel, C., & Friedlander, G. (1996) · Biochemical Journal · doi:10.1042/bj3200615 · Cited by 27
Functional 5-HT receptors in human occipital artery
Verheggen, R., Meier, A. A., Werner, I., et al. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0878-9 · Cited by 25
Moreno, L., Martínez-Cuesta, M. Á., Piqu�, J. M., Bosch, J., & Esplugues, J. V. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168439 · Cited by 25
Gerges, N. Z., Aleisa, A. M., Alhaider, A. A., & Alkadhi, K. A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00283-6 · Cited by 25
Nosjean, A., Franc, B., & Laguzzi, R. F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11277-4 · Cited by 25
The love of a lifetime: 5-HT in the cardiovascular system
Watts, S. W. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90676.2008 · Cited by 25
Self-citationTHE RELATIVE TOXICITY OF AMITRIPTYLINE, IMIPRAMINE, MAPROTILINE AND MIANSERIN IN RABBITSin vivo
Hughes, I. E., & Radwan, S. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb07834.x · Cited by 24
Key, B. J., & Wigfield, C. C. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90032-k · Cited by 24
Yokota, S., Ishikura, Y., & Ono, H. (1987) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.45.335 · Cited by 23
Heart valve cardiomyocytes of mouse embryos express the serotonin transporter SERT
Pavone, L. M., Spina, A., Muto, R. L., Santoro, D., Mastellone, V., & Avallone, L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.152 · Cited by 22
Janiak, P., Lainée, P., Grataloup, Y., Luyt, C. E., Bidouard, J., Michel, J., OCONNOR, S., & Herbert, J. M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00538-2 · Cited by 22
Central mediation of the antihypertensive effect of pargyline in spontaneously hypertensive rats
Fuentes, J., Ordaz, A., & Neff, N. H. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90099-2 · Cited by 21
Gaciong, Z. A., Placha, G., & for Polish Sibutramine Study Group (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001877 · Cited by 21
Merahi, N., & Laguzzi, R. F. (1995) · Brain Research · doi:10.1016/0006-8993(94)01202-s · Cited by 20
Ferreira, H. S., Oliveira, E., Faustino, T. N., Silva, E. D. C. E., & Fregoneze, J. B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.054 · Cited by 20
Feťkovská, N., Amstein, R., Ferracin, F., Regenass, M., Bühler, F. R., & Pletscher, A. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.267 · Cited by 20
Effect of serotonin on small intestinal contractility in healthy volunteers
Hansen, M., Arif, F., Gregersen, H. N., Bruusgaard, H., & Wallin, L. (2008) · Physiological Research · doi:10.33549/physiolres.931177 · Cited by 20
Role of central 5-HT3 receptors in the control of blood pressure in stressed and non-stressed rats
Ferreira, H. S., Silva, E. D. C. E., Cointeiro, C., Oliveira, E., Faustino, T. N., & Fregoneze, J. B. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.063 · Cited by 18
Hemodynamic effects of activation of renal and mesenteric sensory nerves in rats
Janssen, B. J., van Essen, H., Struijker-Boudier, H. A. J., & Smits, J. F. M. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.257.1.r29 · Cited by 18
Characterisation of nicotine receptors on human peripheral blood mononuclear cells (PBMC)
Wongsriraksa, A., Parsons, M. E., & Whelan, C. J. (2009) · Inflammation Research · doi:10.1007/s00011-008-8171-x · Cited by 17
Chudasama, H., & Bhatt, P. A. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-080 · Cited by 17
David, P., Quail, D., Gandhi, P., Walker, D. J., & Peveler, R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.08.023 · Cited by 17
Hypotensive Effects of 5-HT1A Receptor Agonists on the Ventrolateral Medullary Pressor Area in Dogs
Dabiré, H., Laubie, M., & Schmitt, H. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199001001-00008 · Cited by 17
Finberg, J. P. M., Gross, A., Bar‐Am, O., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706908 · Cited by 14
Cited by
Minireview: Gut microbiota: The neglected endocrine organ
Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192
Tryptophan metabolism in health and disease
Xue, C., Li, G., Zheng, Q., Gu, X., Shi, Q., Su, Y., Chu, Q., Yuan, X., Bao, Z., Lu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.004 · Cited by 961
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Self-citationGut–Brain Axis in Regulation of Blood Pressure
Yang, T., & Zubcevic, J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00845 · Cited by 74
“More than 90% of the 5-HT in our body is synthesized in the gut, and 5-HT either diffuses into circulation where it is sequestered by platelets, or it binds to its receptors that are widely distributed on enteric neurons, enterocytes, and immune cells (Watts et al., 2012).”
Background
Metadata
- Authors
- Watts, S. W., Morrison, S. F., Davis, R. P., & Barman, S. M.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 64
- Issue
- 2
- Pages
- 359-388
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2098697701
- Cited by
- 396
- References
- 216
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.